
InvenireX
InvenireX is developing ultra-sensitive nucleic acid detection instrumentation for life sciences research.
About
InvenireX is developing ultra-sensitive nucleic acid detection instrumentation for life sciences research.
Key facts
- Website
- invenirex.co.uk
- Headquarters
- San Francisco, United States
- Founded
- 2022
- Total funding
- $4M (Seed)
- Valuation
- Private
- Business model
- B2B
- Tags
- AI InfrastructureDrug DiscoveryBiotechFoundation ModelGenerative AI
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 18 Nov 2025 | Seed | $3M | Parkwalk Advisors, Northern Gritstone |
| 1 May 2023 | Undisclosed round | $2M | - |
Tech stack
Detected on invenirex.co.uk, last scanned 19 Sept 2026. Run your own scan
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has InvenireX raised?
InvenireX has raised a total of $4M in funding. The most recent round on record is Seed.
